HR 2115 — Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Last action — Received in the Senate and Read twice and referred to the Committee on Finance.
-
✓Introduced
-
✓In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 116th Congress. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.
Bill Text
What changed in the latest version
5 added · 1 removedPlain-language change summary
The updated version of H.R. 2115 includes a new header indicating that it has been referred to the Senate and the Committee on Finance. The previous header identifying the bill as "Engrossed in House" has been removed. This change signifies the bill's progression in the legislative process as it moves from the House to the Senate for consideration.
2115 EngrossedReferred in HouseSenate (EH)](RFS)] <DOC> 116th CONGRESS 1st Session H.
2115 _______________________________________________________________________ ANIN ACTTHE ToSENATE amendOF titlesTHE XIUNITED andSTATES XVIIIOctober of29, the2019 SocialReceived; Security Act to provide greater transparency for discounts provided by manufacturers, to include real-time benefit information as part of a prescription drug plan's electronic prescription program under the Medicare program, and for other purposes.
read twice and referred to the Committee on Finance _______________________________________________________________________ AN ACT To amend titles XI and XVIII of the Social Security Act to provide greater transparency for discounts provided by manufacturers, to include real-time benefit information as part of a prescription drug plan's electronic prescription program under the Medicare program, and for other purposes.
Clerk.CHERYL L.
116thJOHNSON, CONGRESSClerk. 1st Session H.
R.
2115 _______________________________________________________________________ AN ACT To amend titles XI and XVIII of the Social Security Act to provide greater transparency for discounts provided by manufacturers, to include real-time benefit information as part of a prescription drug plan's electronic prescription program under the Medicare program, and for other purposes.
View plain text versions (3)
- Referred in Senate View text Current html October 29, 2019
- Engrossed Engrossed in House html October 28, 2019
- Introduced Introduced in House html April 08, 2019
Action History
-
Introduced in House
-
Introduced in House
-
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Referred to the Subcommittee on Health.
-
Referred to the Subcommittee on Health.
-
Subcommittee Hearings Held.
-
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
-
Considered under suspension of the rules. (consideration: CR H8516-8519)
-
DEBATE - The House proceeded with forty minutes of debate on H.R. 2115.
-
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
-
Considered as unfinished business. (consideration: CR H8520-8521)
-
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586).(text: CR H8516)
-
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)
-
Motion to reconsider laid on the table Agreed to without objection.
-
The title of the measure was amended. Agreed to without objection.
-
Received in the Senate and Read twice and referred to the Committee on Finance.
Sponsors
- Abigail Davis Spanberger · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
- Spanberger, Abigail Davis Democratic
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors HR 2115?
- HR 2115 is sponsored by Spanberger, Abigail Davis (Democratic).
- What is the current status of HR 2115?
- This bill died with 116th Congress. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 2115?
- Track HR 2115 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 2115
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 2115
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →